Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2013
12/12/2013WO2013183718A1 Screening method, protein instability and/or stability inducers, and protein activity assesment
12/12/2013WO2013183327A1 Method for producing compound having condensed ring structure, compound having condensed ring structure, and organic light-emitting device using same
12/12/2013WO2013182993A1 Method for preparing nitrogen compounds
12/12/2013WO2013181741A1 Imino compounds as protecting agents against ultraviolet radiations
12/12/2013WO2012161071A8 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
12/12/2013US20130331409 Condensed heterocyclic compound
12/12/2013US20130331401 Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates
12/12/2013US20130331397 Compounds and compositions as trk inhibitors
12/12/2013US20130331378 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
12/12/2013US20130331375 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
12/12/2013US20130331374 Protein Kinase C Inhibitors and Uses Thereof
12/12/2013US20130331369 3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
12/12/2013CA2875966A1 Compounds and compositions for modulating egfr activity
12/12/2013CA2875507A1 Solid forms of an antiviral compound
12/12/2013CA2875305A1 Fbxo3 inhibitors
12/12/2013CA2875165A1 Imino compounds as protecting agents against ultraviolet radiations
12/11/2013EP2672540A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
12/11/2013EP2671882A1 pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
12/11/2013EP2671881A1 Pesticidally active pyridyl- and pyrimidyl- substituted thiazole derivatives
12/11/2013EP2671875A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
12/11/2013EP2671582A1 Ring-fused heterocyclic derivative
12/11/2013EP2670752A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
12/11/2013EP2670751A1 Methods of making hiv attachment inhibitor prodrug compound and intermediates
12/11/2013EP2670750A1 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
12/11/2013EP2670749A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/11/2013EP2670748A2 7-azaindole derivatives
12/11/2013CN103443102A Bicyclic carboxamide inhibitors of kinases
12/11/2013CN103443099A Compositions and methods for modulating FXR
12/11/2013CN103443080A Sulfonamide compounds having TRPM8 antagonistic activity
12/11/2013CN103442712A Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/11/2013CN103442568A Furo[3,2-d]pyrimidine compounds
12/11/2013CN103436254A Functional multi-nitrogen heterocyclic ring fluorescent probe, preparation method and application thereof
12/11/2013CN103435613A Method for preparing coronaridine
12/11/2013CN103435612A Compound for treating diabetes mellitus
12/11/2013CN103435611A Multi-target point alpha-pyridoin compounds and preparation method and application thereof
12/11/2013CN103435610A Preparation method of imidazo-[1,2-a] pyridine compound
12/11/2013CN103435609A Copper-catalyzed synthetic method of imidazo[1,2-a]pyridine-3-formaldehyde compound
12/11/2013CN103435608A Pyridino-miazines PLK1 (Polo-like kinase 1) inhibitor and application thereof
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435601A Multiple-target-point flavone-quinolinone compound and preparation method and applications thereof
12/11/2013CN103435600A Alkyl connection quinolinone-furanone compounds and preparation method and application thereof
12/11/2013CN103435595A Acetylenic heteroaryl compounds
12/11/2013CN103435561A Novel D-amino acid oxidase inhibitor and preparation and application thereof
12/11/2013CN102603738B Stable moxifloxacin hydrochloride compound
12/11/2013CN102149713B Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
12/11/2013CN101622255B Spirocyclic cyclohexane derivatives
12/11/2013CN101516844B 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
12/11/2013CN101405281B Inhibitors of the interaction between MDM2 and P53
12/10/2013US8604195 Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1
12/10/2013US8604050 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
12/10/2013US8604049 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
12/10/2013US8604048 Pyridocarbazole type compounds and applications thereof
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8604029 2-[(2-substituted)-indolizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
12/10/2013CA2700824C Heterocyclic compounds as crth2 receptor antagonists
12/10/2013CA2495442C Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
12/05/2013WO2013181579A2 Tetrahydropyrazolopyrimidine compounds
12/05/2013WO2013181415A1 Synthesis of pyrrolo [2, 3 - b] pyridines
12/05/2013WO2013181075A1 Isotopically labeled biaryl urea compounds
12/05/2013WO2013180656A1 ICMT Inhibitors
12/05/2013WO2013180265A1 Heterocyclic compound
12/05/2013WO2013180197A1 NOVEL β-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME
12/05/2013WO2013180194A1 Fused heterocyclic compound
12/05/2013WO2013180193A1 Fused heterocyclic compound
12/05/2013WO2013180183A1 Aromatic heterocyclic derivative and pharmaceutical
12/05/2013WO2013179049A1 Spiro derivatives as voltage - gated sodium channel modulators
12/05/2013WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives
12/05/2013WO2013178572A1 Triazolo compounds as pde10 inhibitors
12/05/2013WO2013178569A1 Pyrrolidino heterocycles
12/05/2013WO2013177713A1 Process for preparation of an antifolate agent
12/05/2013WO2013144737A3 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases
12/05/2013WO2012083122A8 Inhibitors of influenza viruses replication
12/05/2013US20130324730 PROCESS FOR OBTAINING COMPOUNDS DERIVED FROM TETRAHYDRO-beta-CARBOLINE
12/05/2013US20130324725 Aminopyrimidines useful as kinase inhibitors
12/05/2013US20130324571 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
12/05/2013US20130324557 Compounds useful as modulators of trpm8
12/05/2013US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists
12/05/2013US20130324547 Tetrahydropyrazolopyrimidine compounds
12/05/2013US20130324528 Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5
12/05/2013US20130324527 Imidazopyridines as respiratory syncytial virus antiviral agents
12/05/2013US20130324526 [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
12/05/2013US20130324518 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130324516 Aminoquinazoline and pyridopyrimidine derivatives
12/05/2013US20130324512 Super-oxide dismutase mimetics
12/05/2013CA2874987A1 Heterocyclic compound
12/04/2013EP2669967A1 Electronic device including phenanthroline derivative
12/04/2013EP2669285A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
12/04/2013EP2669284A1 Compound having pyridoindole ring structure and substituted bipyridyl group, and organic electroluminescent element
12/04/2013EP2669283A1 Oxazolidinone derivative having 7-membered hetero ring
12/04/2013EP2668186A1 Pharmaceutical composition comprising pyridone derivatives
12/04/2013EP2668185A1 Pharmaceutical composition comprising pyridone derivatives
12/04/2013EP2668184A1 Derivatives of azaindazole or diazaindazole type as medicament
12/04/2013EP2668165A1 Novel tetrahydroquinoline derivatives
12/04/2013EP2668157A1 Protease activated receptor 2 (par2) antagonists
12/04/2013EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013CN103429589A Oxazine derivatives and their use in the treatment of neurological disorders
12/04/2013CN103429582A MST1 kinase inhibitors and method of use thereof
12/04/2013CN103421009A Method for extracting corynoxeine from uncaria macrophylla
12/04/2013CN103421008A Multiple target point furanone-quinolinone compounds and preparation method and usage of multiple target point furanone-quinolinone compounds
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 646